Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any non-syndromic X-linked intellectual disability in which the cause of the disease is a mutation in the PAK3 gene.
Features include always present findings: Upslanted palpebral fissure, Prominent fingertip pads, Anteverted nares, and Low muscle tone (hypotonia) and others; and very common findings: Poor speech, Aggressive behavior, and Open mouth. 38 total HPO annotations.
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 9:39 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 15 | Poor speech, Bilateral tonic-clonic seizure, Seizure |
Head and neck | 5 | Flat face, Thin upper lip vermilion, High palate |
Muscles | 2 | Low muscle tone (hypotonia), Delayed gross motor development |
Arms and legs | 1 | Prominent fingertip pads |
Growth and development | 1 | Short stature |
PAK3 function has not been fully characterized.
Intellectual disability, X-linked 30 is associated with mutations in the PAK3 gene on chromosome X.
Genetic testing for PAK3 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for intellectual disability, X-linked 30 has been reported in the published literature.
Phenotype severity distribution: 17 always present features, 3 very common features, 10 common features.
No clinical trials have been registered for intellectual disability, X-linked 30.
73 publications have been identified in PubMed for intellectual disability, X-linked 30. Research spans Basic Science / Preclinical (38%), Clinical Trial Publication (16%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 28 | 38% |
Clinical study results | 12 | 16% |
Disease patterns and progression | 12 | 16% |
Research summaries | 8 | 11% |
Patient case studies | 6 | 8% |
Testing and diagnosis research | 4 | 5% |
New treatment approaches | 3 | 4% |
Klusek J (2026). [PMID: 41555826](https://pubmed.ncbi.nlm.nih.gov/41555826/). *Journal of Alzheimer's disease : JAD*. [Clinical Trial Publication]
Guerrero-Gonzalez JM (2026). [PMID: 42063232](https://pubmed.ncbi.nlm.nih.gov/42063232/). *Brain Behav*. [Basic Science / Preclinical]
Savvidou A (2026). [PMID: 41980228](https://pubmed.ncbi.nlm.nih.gov/41980228/). *Neurology*. [Epidemiology / Natural History]
Peery E (2026). [PMID: 41208002](https://pubmed.ncbi.nlm.nih.gov/41208002/). *Journal of assisted reproduction and genetics*. [Clinical Trial Publication]
Boelaert K (2026). [PMID: 41508830](https://pubmed.ncbi.nlm.nih.gov/41508830/). *The Journal of clinical endocrinology and metabolism*. [Clinical Trial Publication]
Tkemladze T (2026). [PMID: 41044236](https://pubmed.ncbi.nlm.nih.gov/41044236/). *European journal of human genetics : EJHG*. [Review / Meta-Analysis]
Smolyarchuk EA (2026). [PMID: 41705613](https://pubmed.ncbi.nlm.nih.gov/41705613/). *Ter Arkh*. [Clinical Trial Publication]
Rabin R (2026). [PMID: 41531333](https://pubmed.ncbi.nlm.nih.gov/41531333/). *American journal of medical genetics. Part A*. [Basic Science / Preclinical]
Maltman N (2026). [PMID: 41403372](https://pubmed.ncbi.nlm.nih.gov/41403372/). *Autism : the international journal of research and practice*. [Basic Science / Preclinical]
Byiers B (2026). [PMID: 41340519](https://pubmed.ncbi.nlm.nih.gov/41340519/). *Journal of intellectual disability research : JIDR*. [Epidemiology / Natural History]